Brief: Neurobo Pharmaceuticals Announces Up To $70 Mln Concurrent Private Placement And Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 24 (Reuters) - Neurobo Pharmaceuticals Inc
NRBO.O :
* NEUROBO PHARMACEUTICALS ANNOUNCES UP TO $70 MILLION
CONCURRENT
PRIVATE PLACEMENT AND REGISTERED DIRECT OFFERING PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* NEUROBO PHARMACEUTICALS: WARRANTS EXPECTED TO PROVIDE CASH
RUNWAY TO COMPLETE PHASE 1 PART 3 CLINICAL TRIAL
Source text for Eikon: ID:nPn5m622a
Further company coverage: NRBO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise